EBR Systems(EBRCZ)
SUNNYVALE, CABiotechnology
Focus: EBR Systems is a public biotech company pioneering wireless cardiac stimulation technology for heart failure treatment. The company operates at a modest commercial scale with $2M in FY2025 revenue while maintaining significant R&D investment.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
11-1 this month
Stable — net -1 jobs in 30d
5 added, 6 removed. Backfill posture.
Should You Work at EBR Systems?
AI assessmentHigh-risk, high-reward opportunity for risk-tolerant professionals seeking early-stage innovation but with material concerns about company viability without immediate capital infusion.
Why Work Here
- Cutting-edge medical device technology (wireless cardiac stimulation) addressing large cardiovascular disease market
- Early commercialization phase with 13 active job openings suggests growth trajectory and team expansion opportunities
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Pipeline & Clinical Trials
WiCS-LV System
Cardiac Resynchronization TherapyClinical Trials (1)
NCT02610673WiCS-LV Post Market Surveillance Registry
N/AHelp build intelligence for EBR Systems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.